Release Date: 18/07/14 15:26 Summary: BIOSHARES CLINICAL TRIALS PRESENTATION Price Sensitive: No Download Document 133.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%